Treatment of benign breast disease with danazol: a follow-up report.

Aksu Mf, M F Aksu, Tzingounis Va, V A Tzingounis, Greenblatt Rb, R B Greenblatt
The Journal of reproductive medicine · 1978 · vol. 21(3) , pp. 181–4 · PMID:722702 · W2285714321
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

Danazol treatment of benign breast disease provided significant relief of pain, tenderness, and nodosities, with low recurrence rates and a notable incidence of conception in infertile patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

One hundred thirty-five women with benign breast disease (BBD) were treated with danazol, an impeded androgen. Their ages ranged from 19 to 60 years (mean age, 30). The dose varied from 100 to 800 mg per day for 90 to 180 days, depending upon the severity of the disorder. Overall relief of pain was observed in 97% and of tenderness in 90.5%. There was complete or marked improvement of nodosities in 73%. Seventy-eight patients were followed every six months for two to four years. The recurrent symptoms were pain in 6%, tenderness in 6% and nodosities in 10%. Incidentally, we found that 29.3% of infertile women with BBD conceived within 24 months after cessation of a course of therapy. The side effects, when present, were trivial.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Breast Diseases Danazol Pregnadienes Adult Breast Diseases Danazol Danazol Endometriosis Endometriosis Female Follow-Up Studies Humans Menstruation Menstruation Middle Aged Pregnadienes

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-14T05:58:53.789372+00:00
License: CC0 · commercial use OK